CARLOS A. TRUJILLO

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

PharmaCyte Biotech, Inc.

Filing Date Source Excerpt
2023-06-05 Carlos A. Trujillo (8) 18,400 * Includes 8,000 shares issuable upon the exercise of options to purchase common stock and 10,400 shares upon the vesting of restricted stock units.
2023-07-31 Carlos A. Trujillo - Director, includes 8,000 shares issuable upon the exercise of options to purchase common stock and 10,400 shares upon the vesting of restricted stock units.

Data sourced from SEC filings. Last updated: 2026-02-03